Is GSK dividend safe?

Is GSK a good dividend stock?

Analysts expect the stock’s EPS to grow at a 4.4% rate per annum over the next five years. GSK distributes $2.17 in dividends annually, which translates to a 5.18% dividend yield. The company’s dividend has grown at a 5.4% rate over the past four years.

Is GSK a safe stock?

In aggregate, GlaxoSmithKline currently has a Value Score of A, putting it into the top 20% of all stocks we cover from this look. This makes GlaxoSmithKline a solid choice for value investors, and some of its other key metrics make this pretty clear too.

Is GSK dividend sustainable?

As a great dividend stock, GlaxoSmithKline has two things going for it: consistent growth and a high but sustainable yield. The 6.6% yield it boasted in 2015 may not be back for a while, but the current yield gives the dividend room to grow.

Is GSK a good buy?

According to the Financial Times, five analysts rate GSK stock a buy; six say Glaxo’s share price has the potential to outperform the market in the next 12 months; 16 have a hold rating in place; and two say GSK shares will underperform. There are no sell ratings.

IT IS INTERESTING:  You asked: Are stock dividends ordinary or qualified?

Did GSK cut dividend?

Glaxo (ticker: GSK) said that the combined dividend from the stay-behind company, referred to as New GSK, and the consumer health spinoff would be approximately 55 pence per share in 2022, a 31% reduction from the 2021 dividend. … Glaxo shares were up 2.3% at 10:42 a.m. Wednesday. On a media call early Wednesday.

Will Glaxo cut dividend?

GlaxoSmithKline (GSK) boss Dame Emma Walmsley has attempted to hold off investor pressure with a new strategy announcement today, promising a “step-change in growth and performance” at the healthcare giant. However the pharma giant will cut its dividend to invest more in its drugs pipeline.

Is GSK stock a buy or sell?

For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25).

Momentum Scorecard. More Info.

Zacks Rank Definition Annualized Return
1 Strong Buy 25.60%
2 Buy 19.21%
3 Hold 10.85%
4 Sell 6.62%

Is GSK a Buy Sell or Hold?

GlaxoSmithKline PLC holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

What is the dividend for GSK?

GSK Dividend History

Ex/EFF DATE TYPE CASH AMOUNT
02/18/2021 CASH $0.629
11/12/2020 CASH $0.509
08/13/2020 CASH $0.485
05/14/2020 CASH $0.466

How much will GSK cut dividend?

The dividend will be cut to 55 pence in 2022 — an aggregate number that includes some contribution from the consumer business. The payment from New GSK will be 45 pence in 2023.

IT IS INTERESTING:  Which is the best bank to invest money in South Africa?

Is GlaxoSmithKline a dividend aristocrat?

UK Dividend Aristocrat #5: GlaxoSmithKline Plc.

What does GSK split mean for shareholders?

GSK is to split itself in two by demerging its consumer products division. A demerger can create value for shareholders (the 1+1 = 3 part) but GSK is asking investors to trust that this plays out while also having to accept a much lower dividend (the ‘-½’ part).

Is GSK a UK company?

GlaxoSmithKline (GSK), formerly Glaxo Wellcome, British-based pharmaceutical company with research-and-development centres in the United States, Belgium, and China as well as the United Kingdom.